Transcatheter Embolization and Occlusion Devices Market Size, Share, Analysis & Forecast

The top three players in the global transcatheter embolization and occlusion (TEO) devices market accounted for over 63% in 2015. Medtronic, plc, Cook Medical, and Terumo Corporation are the three companies that together dominated the market in 2015. Transparency Market Research notes that the degree of competition is moderate due to market consolidation as a result of frequent acquisitions. The competitive rivalry is influenced by the presence of large global players and few local manufacturers of transcatheter embolization and occlusion devices.
 
“Business agreements and partnerships among key market players will enable them to expand their global reach and market their products to newer regions,” the lead analyst recommends. In January 2016, Terumo Corporation expanded its strategic alliance with Quirem Medical and became the exclusive global distributor of radioembolization solutions developed by Quirem Medical.

Request to view Sample Report:   https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2242

North America Emerges as Leading Regional Segment

 

In terms of percentage share contribution, the embolization coils segment is expected to reflect a share of 39.5% by 2024. Registering an impressive CAGR of 13.2% from 2016 to 2024 in terms of revenue, embolization particles are likely to emerge as a highly lucrative product segment in the global transcatheter embolization and occlusion devices market. By application, peripheral vascular disease was the leading segment in 2015, while oncology is slated to be the most attractive segment of the market.

Based on end use, the hospitals segment accounted for a significant share in the global transcatheter embolization and occlusion devices market in terms of revenue. In terms of percentage share contribution, North America is expected to account for 32.3% by 2024, emerging as the leading regional segment of the global transcatheter embolization and occlusion devices market.

Request to download and view full ToC @ https://www.transparencymarketresearch.com/report-toc/2242

Rising Prevalence of Cancer Boosts Demand for Transcatheter Embolization and Occlusion Devices

The TEO devices market is fueled by a number of factors, including an increase in the adoption of minimally invasive surgeries, a rise in the prevalence of cancer, technological innovations, and changing demographics and lifestyle leading to an increase in peripheral vascular diseases.

“Embolization is a minimally invasive surgery that marks a significant advancement in medical technologies,” the author of the report states. “The adoption of minimally invasive surgeries has increased significantly over the years owing to the various advantages they present, including less post-operative pain, reduced blood loss, shorter hospital stay, and faster recovery.”

Cancer is one of the leading causes of mortality and morbidity around the world and the rising prevalence of cancer globally has driven the demand for chemembolization and radioembolization. This has, in turn, boosted the demand for transcatheter embolization and occlusion devices.

In contrast, frequent product recalls, stringent regulations governing product approvals, the lack of skilled professionals, and the lack of reimbursement policies in emerging markets threaten to impede the global market for transcatheter embolization and occlusion devices.

View Report @ https://www.transparencymarketresearch.com/transcatheter-embolization-occlusion-devices-market.html

About Us

 

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.